Low-Dose Naltrexone Therapy. Prescribed for Inflammation, Not Addiction
Naltrexone is FDA-approved at 50mg for addiction. At 0.5–4.5mg, it works through a completely different mechanism, one that targets immune dysregulation and systemic inflammation. That off-label use requires a licensed provider, a clinical evaluation, and labs. Telehealth LDN therapy across CO, AZ, ID, ME, MT, NH, NM, WA, and WY.
What Is Low-Dose Naltrexone?
Naltrexone is an opioid antagonist — a medication that blocks opioid receptors in the brain and body. At its FDA-approved dose of 50mg, it is used to treat opioid and alcohol use disorder by preventing the euphoric effect of these substances. At a fraction of that dose — typically between 0.5mg and 4.5mg — the pharmacology changes entirely. The blockade is brief, lasting only a few hours. That transient antagonism triggers a rebound upregulation of the body's own endorphin and enkephalin production, which in turn produces measurable changes in immune signaling: reduced glial cell activation, antagonism of toll-like receptor 4 (TLR4), and recalibration of the Th1/Th2 immune balance. These effects are not present at the 50mg therapeutic dose — they are specific to the low-dose window. Low-dose naltrexone (LDN) is not a compounded experimental drug; it is pharmacy-compounded naltrexone at a clinically specific dose, prescribed by a licensed provider, and dispensed under pharmacy regulations. Steel City prescribes LDN after a clinical intake, baseline labs, and a documented assessment of your inflammatory picture.
What Low-Dose Naltrexone Actually Does in the Body?
At standard doses, naltrexone blocks opioid receptors to prevent the euphoric effect of opioids. At a fraction of that dose, typically between 0.5mg and 4.5mg, something different happens. The blockade is transient, lasting only a few hours. During that window, your body compensates by upregulating its own endorphin and enkephalin production. The downstream effect is a recalibration of immune signaling: specifically, reduced activation of glial cells in the central nervous system and antagonism of toll-like receptor 4 (TLR4), a key driver of neuroinflammation and systemic inflammatory burden.
That mechanism is why LDN has been studied in conditions characterized by immune dysregulation, not because it suppresses immune function, but because it modulates it. The difference matters. At Steel City, LDN is prescribed after a clinical intake that reviews your inflammatory markers, medication list, and health history. We monitor hs-CRP over time because we want objective data, not just symptom reports.
What are the benefits of LDN at Steel City?
Reduced Systemic Inflammation:
Hs-CRP is your primary objective marker. Most patients don't see meaningful reductions before the 8-week mark, and some take 3–6 months of consistent dosing to show measurable change. This is a long-game therapy by design — titration is slow, and so is the evidence accumulating in your labs.
Immune Modulation Without Suppression:
LDN's effect on the Th1/Th2 immune balance underlies its use in patients with autoimmune conditions. It doesn't suppress immune response the way biologics or steroids do. It retrains the signaling pattern.
Neuroinflammatory Pain Pathway Interruption
Glial cell activation in the central nervous system amplifies pain signaling. LDN reduces microglial activation, which is why patients with chronic widespread pain and fibromyalgia-pattern symptoms are frequently candidates. The mechanism is neurological, not analgesic.
Cognitive Clarity and Brain Fog
Chronic neuroinflammation has downstream effects on cognitive performance. Patients with elevated inflammatory burden often report brain fog as a primary complaint. When inflammation is the driver, addressing it at the TLR4 level has cognitive effects that aren't separate from the anti-inflammatory effect — they're the same mechanism, different symptom.
Sleep Quality
LDN is dosed at bedtime during the titration phase. Sleep disturbance is a common early side effect as the dose increases. Once a therapeutic dose is established, many patients report improved sleep quality, though this is a secondary outcome rather than the primary therapeutic target.
How Low-Dose Naltrexone Works at Steel City
Step 1:
Clinical intake and medication review: LDN has one absolute contraindication: opioid medications. The intake isn't a formality. We review your full medication list, health history, and inflammatory picture before prescribing anything. Patients currently using opioids are not candidates.
Step 2:
Baseline labs: CMP and hs-CRP are required before initiation. The CMP gives us a metabolic baseline; hs-CRP is the inflammatory marker we'll track over time to assess whether the therapy is working objectively. Labs are ordered through our clinic and run through our designated lab network.
Step 3:
Telehealth consultation: A 30-minute provider visit to review your intake, labs, and clinical suitability. If LDN is appropriate, your prescription is initiated at this visit.
Step 4:
Titration, slower is better: LDN is not started at the therapeutic dose. Typical initiation is 0.5mg, titrating upward based on your response. Moving too fast increases the likelihood of vivid dreams, sleep disruption, and transient headaches. We pace the titration based on your tolerance rather than a fixed schedule.
Step 5:
Ongoing monitoring: Follow-up labs at 8 weeks, then every 3–6 months based on your clinical response. We're tracking hs-CRP against baseline to confirm the therapy is producing an objective result. Refills are not authorized if labs are overdue.
| Item | Cost |
|---|---|
| LDN Medication | Pharmacy pass-through rates |
| Baseline Labs — CMP + hs-CRP (Rupa Health) | ~$30.92 |
| Follow-Up Labs — CMP + hs-CRP (Rupa Health) | ~$30.92 |
Your LDN Provider
Steel City's LDN program is managed by board-certified nurse practitioners holding active prescriptive authority in all licensed states. Every patient undergoes a full clinical intake, baseline labs, and a documented clinical evaluation before any prescription is issued. LDN is not a first-appointment refill — it is a monitored protocol with scheduled follow-up labs at 8 weeks and ongoing dose titration based on your response. You have direct access to your provider through Spruce Health throughout the course of your therapy.
Jeremiah Velasquez FNP-BC, AGACNP-BC
Learn more about the anti-inflammatory benefits of LDN
The Clinical Guide to
Low-Dose-Naltrexone
You've Lived With the Symptoms Long Enough.
Chronic inflammation has a way of becoming normal.
The fatigue. The aches. The flare-ups. The brain fog. The feeling that you're managing your condition instead of truly improving it.
If you've been told to live with it, monitor it, or accept it as your new baseline, you deserve the opportunity to explore another approach.
At Steel City HRT & Weight Loss, our Low-Dose Naltrexone (LDN) Program is designed for individuals looking to understand the role inflammation and immune dysregulation may be playing in their health. Through a comprehensive telehealth consultation, we'll review your health history, discuss your goals, and determine whether LDN may be an appropriate option for your unique situation.
Just a conversation with a double board-certified Nurse Practitioner who understands that "managed" isn't always the same as feeling well.
FAQs
Isn't naltrexone an addiction medication?
At 50mg, yes, it's FDA-approved to block the euphoric effect of opioids and alcohol. At 1.5–4.5mg, the pharmacology is entirely different. The blockade is short-lived, triggering a compensatory increase in your body's endorphin production. That rebound effect, repeated nightly, produces immune-modulating changes that aren't present at higher doses, the same drug, a fundamentally different mechanism. We're prescribing off-label at low doses, and we'll document the clinical rationale for every prescription we write.
Can I take LDN if I'm on opioid pain medications?
No. This is an absolute contraindication, not a precaution. LDN and opioids taken together can precipitate acute opioid withdrawal, which can require hospitalization. If you are currently prescribed any opioid, Oxycodone, Hydrocodone, Tramadol, Buprenorphine, Codeine, or any related compound, or are ever prescribed an opioid for an acute injury or surgery while on LDN, you must notify us immediately and suspend the therapy.
Is this FDA-approved?
Naltrexone is FDA-approved at 50mg for opioid and alcohol use disorder. Its use at low doses (0.5–4.5mg) for immune modulation and inflammation is off-label. Off-label prescribing is legal, common, and clinically appropriate when the provider has a documented rationale and the patient has given informed consent. We disclose this clearly at intake. The compound itself is not experimental and is not sourced from a gray-market supplier; it is pharmacy-compounded naltrexone at a specific low dose, prescribed by name to you, dispensed under pharmacy regulations.
How long before I see results?
Titration to a therapeutic dose typically takes 4–8 weeks, depending on how you tolerate dose increases. Objective improvement in hs-CRP, the inflammatory marker we track, often isn't visible before the 3-month mark. Some patients notice symptomatic changes earlier. The lab data tends to lag the subjective experience by 4–8 weeks. If your hs-CRP hasn't moved after 6 months of consistent therapeutic dosing, we reassess the protocol rather than continuing indefinitely.
I'm already on TRT, GLP-1, or peptide therapy. Does LDN fit?
LDN is frequently used as an adjunct to other protocols. Systemic inflammation is a common driver of suboptimal hormone response; patients on TRT with elevated hs-CRP often see their optimization outcomes improve when the inflammatory burden is addressed. The same logic applies to GLP-1 therapy, where metabolic inflammation can blunt the medication's full effect
What does the medical management subscription cover?
The $49 every-four-weeks fee covers clinical oversight, provider review, dose titration, lab trend analysis, opioid screening compliance, and HIPAA-compliant secure messaging. Naltrexone medication is billed separately at pharmacy pass-through rates. Refills are not authorized if your subscription has lapsed or your required labs are overdue.
What conditions is LDN used for at Steel City?
LDN is not indicated for a specific named diagnosis at Steel City — it is indicated for documented inflammatory burden, measured by hs-CRP, and immune dysregulation that may be contributing to a patient's symptoms. Conditions commonly associated with this pattern include fibromyalgia, autoimmune conditions (including Hashimoto's, lupus, and MS), chronic fatigue, post-viral inflammatory syndromes, and inflammatory pain. LDN is not a substitute for disease-modifying therapies in serious autoimmune conditions; it is typically used as an adjunct. Candidacy is determined by clinical intake and labs, not by self-reported diagnosis.
Can I get LDN if I live outside Colorado?
Steel City prescribes LDN via telehealth to patients physically located in Colorado, Arizona, Idaho, Maine, Montana, New Hampshire, New Mexico, Washington, and Wyoming at the time of their visit. You do not need to be a state resident — only physically present in a licensed state during your telehealth appointment. Arkansas is licensed but not currently served. Prescriptions are filled through a licensed compounding pharmacy and shipped directly to you.
Operated by Steel City Men’s Health and Testosterone LLC
Clinic Hours
Medical Services
Labs
Hormone Replacement Therapy (HRT)
Testosterone Replacement Therapy (TRT)
Weight Loss
Peptides
Supplements
Policies & Compliance
Legal & Disclosures
Services are provided by licensed medical professionals.
No prescription is guaranteed.
Medications are prescribed only after a medical evaluation.
The Clinic does not sell or dispense medications.
Compounded medications, when prescribed, are not FDA-approved.
Telehealth services are not appropriate for emergencies.
© Copyright 2026 Steel City HRT & Weight Loss. All rights reserved.. All rights reserved. Designed by Topline
Steel City HRT & Weight Loss provides medical services only in states where its providers are properly licensed. Telehealth services are available only to patients physically located in states of licensure at the time of the visit.
This website is for informational purposes only and does not constitute medical advice. Individual results vary. No treatment outcomes are guaranteed.
If you are experiencing a medical emergency, call 911 immediately.